Looks like we have some tapering and buprenorphine recommendations. Some notable persons I see on the connected documentation are: Jane Ballentyne, Mark Sullivan, Stefan Kertesz and Ajay Manhapra

https://www.clinicalpainadvisor.com/home/topics/opioid-addiction/panel-publishes-consensus-recommendations-on-opioid-tapering/">https://www.clinicalpainadvisor.com/home/topi...

Here is the connected document that was linked in the Clinical Pain Advisor article posted above. I still need to read this one but did read the CPA one. https://www.mayoclinicproceedings.org/article/S0025-6196(20)30395-5/fulltext">https://www.mayoclinicproceedings.org/article/S...

Also, I neglected to mention, Penny Cowan of the American Chronic Pain Association is also listed here.
Here’s what’s linked her the ACPA’s website. BDSI. The makers of Belbuca

I need to read the paper closet but at first glance, it appears buprenorphine is recommended for some

https://www.theacpa.org"> https://www.theacpa.org 

Click on “this is pain” to see BDSI advertised/linked to their website.

Since Jane Ballentyne is on this paper and called painful disease patients “couch potatoes” I don’t think she should have a say in what happens to us!
Here’s video proof of her saying it. She should be removed from these positions because of this https://m.youtube.com/watch?v=4xQjfFZ2TrI">https://m.youtube.com/watch...